The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Droplet digital PCR monitoring of BRAF and NRAS plasma DNA as biomarkers of treatment response in stage IV melanoma.
David Polsky
Consultant or Advisory Role - MolecularMD
Other Remuneration - MolecularMD
Jyothirmayee S. Tadepalli
No relevant relationships to disclose
Gregory Chang
No relevant relationships to disclose
Nathaniel H. Fleming
No relevant relationships to disclose
Yongzhao Shao
No relevant relationships to disclose
Anna C. Pavlick
No relevant relationships to disclose
Iman Osman
Other Remuneration - MolecularMD
Manohar Furtado
Consultant or Advisory Role - Bio-Rad
Cynthia Spittle
Employment or Leadership Position - MolecularMD
Paula Stonemetz
Employment or Leadership Position - Bio-Rad
Dawne Shelton
Employment or Leadership Position - Bio-Rad
George Karlin-Neumann
Employment or Leadership Position - Bio-Rad